TRLV Trulieve Cannabis Corp.
XNYS 10.80 DelayedStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
TRLV
$10.80
—
What changed
Recent filings, trades and movesKey stats
$10.80
- 52-Week Range
- $7.82 – $12.93
- YTD
- -6.09%
- IV Rank (30D)
- 84.23
- Straddle Price
- $3.15
- P/C Vol Ratio
- 0.49
- Market Cap
- $2.0B
- Open
- $11.57
- Day Range
- $10.71 – $11.65
- Volume
- 1,327,316
- Prev Close
- $11.56
Fair Value
MODEL: LONG
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.90% |
| Beta vs SPY | 0.99 |
| Cost of Equity (CAPM) | 9.85% (VRP-adj) |
| WACC | 9.44% |
| Volatility Risk Premium | +59.3pp (IV − HV30) |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +3.0% |
| DCF Horizon | 5 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.03 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.2B |
| Return on Equity (TTM) | -61.7% |
| Book / Price | 36.6% — banking bias active (P/B is primary) |
| Quality Score | 0/6 — cyclical/struggling (5y DCF) |
| Market-Implied Growth | -2.4% (reverse-DCF on current price) |
| SMA 50 | $11.21 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $10.69 |
| Bollinger Width / SMA20 | 18.1% (drives anchor stability) |
| Net Debt | $0.0B |
| Market Cap | $2B |
Peers used for multiples: CGC, CRON, TLRY
(filtered from 8 ETF-co-members; sector bias active)
60-Day Conviction
73%
20-Day Fair Value
≈ by Dec 8, 2026
$10.88
α +0.3%
rank 27%
conviction
21%
40-Day Fair Value
≈ by Jan 6, 2027
$11.26
α +3.8%
rank 33%
conviction
88%
60-Day Fair Value
≈ by Feb 4, 2027
$11.21
α +3.3%
rank 37%
conviction
73%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $14.63 | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | |
| Peer EV/EBITDA | n/a | 0% | |
| Peer P/B | $2.50 | 15% | median 0.6× · 3 peers |
| Peer P/S | $7.70 | 15% | median 1.2× · 3 peers |
| Market Anchor (SMA50) | $11.21 | 47% | stability 60% (BB-width) |
| Options Expected (B-L 30d) | $11.24 | 22% | 11 strikes · skew -0.21 |
As of 2026-11-09 · updated
Related
About
- Industry (SIC)
- MEDICINAL CHEMICALS & BOTANICAL PRODUCTS (2833) · industry map
- Exchange
- XNYS
- Market Cap
- $2.0B
- Employees
- 5,000
- List Date
- 2018-09-26
- CIK
- 0001754195
- Last Earnings
- Nov 5 before open · −6.0% vs ±17.9% expected
- Next Earnings
- ~Feb 25, 2027 (estimated)
- Headquarters
- Tallahassee, FL
- Homepage
- https://www.trulieve.com
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '26 | Avg |
|---|---|---|
| Jan | -- | -- |
| Feb | -- | -- |
| Mar | -- | -- |
| Apr | -- | -- |
| May | -- | -- |
| Jun | -14.52% | -14.52% |
| Jul | -10.27% | -10.27% |
| Aug | 33.84% | 33.84% |
| Sep | -7.16% | -7.16% |
| Oct | -5.43% | -5.43% |
| Nov | -2.39%* | -2.39% |
| Dec | -- | -- |
| Total | -12.02% | -12.02% |
* Only 1 year(s) of data available.
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $10.72
SMA 50: $11.19
SMA 200: —
Current: $10.83
EMA 12: $10.99
EMA 26: $10.91
MACD: 0.0736 | Signal: 0.0783
BEARISH
ADX (14): 17.35
RANGE
+DI: 18.84
−DI: 17.30
Momentum Oscillators
RSI (14): 49.12
NEUTRAL
Stoch %K: 55.66
Stoch %D: 64.02
Williams %R: -56.74
Volume & Volatility
BB Upper: $11.67
BB Lower: $9.76
NEUTRAL
OBV: -20,909,242
Vol SMA 20: 1,327,281
Vol ROC: 29.46%
ATR: $0.75
True Range: $0.94
HV 20: 63.1%
HV 30: 65.8%
HV 60: 60.2%
Data Summary
Data Points: 105
Last Updated:
Date Range: 2026-06-10T00:00:00 – 2026-11-06T00:00:00
AI Analysis
Written before TRLV’s Nov 5 earnings report, so it doesn’t reflect the results.
TRLV Stock Analysis Report
Executive Summary
Overall Assessment: NEUTRAL with Confidence Level: 5/10
TRLV presents a mixed technical and sentiment picture with conflicting signals that warrant cautious observation rather than conviction trading. While positive news sentiment and bullish options flow suggest optimism, the stock is trading below its 20-day moving average with deteriorating directional momentum (-DI at 25.57 vs +DI at 18.20). The low beta (0.67) and modest correlation to broader markets (0.12) indicate this cannabis stock operates largely on company-specific catalysts rather than market-driven moves.
Key Drivers:
- Positive news narrative around cannabis sector tailwinds and NYSE listing (June 2026)
- Strong options call volume (315 vs 133 puts) suggesting bullish positioning
- Elevated IV premium (133.1% above realized volatility) indicating expensive options
- Critical technical weakness: price below both SMA 20 ($11.81) and EMA 12 ($11.76)
Primary Risks:
- Bearish directional momentum with -DI significantly above +DI
- Negative OBV (-12.8M) signaling volume flowing into sellers despite price support
- High historical volatility (68.6% HV20) with stretched IV creating potential for vol crush
- Missing 200-day SMA data and limited earnings visibility in cannabis sector
Investment Thesis: TRLV is caught between positive sector narrative and deteriorating technical momentum, with the stock failing to hold above key moving averages despite bullish options positioning. The disconnection between news sentiment and negative OBV suggests retail optimism may not be supported by institutional accumulation. Current risk/reward favors watching for clearer directional conviction before committing capital.
Technical Analysis
Trend Direction
Short-term (1-4 weeks): BEARISH
- Price at $11.19 trading below SMA 20 ($11.81) and EMA 12 ($11.76)
- Failed to hold above both 12 and 26-period EMAs, indicating loss of near-term momentum
- ADX at 32.38 shows strong trending environment, but direction is DOWN
- Current price approaching lower Bollinger Band ($10.81), down 3.4% from midline
Medium-term (1-3 months): NEUTRAL-TO-BEARISH
- SMA 50 at $10.56 provides support but represents only 5.6% downside cushion
- Price remains above the 50-day MA, suggesting intermediate support is holding
- However, lack of 200-day MA data prevents full assessment of longer-term trend health
Long-term (3-12 months): INDETERMINATE
- Missing 200-day SMA ($N/A) severely limits long-term trend assessment
- Data Quality Flag: Absence of 200-day moving average is significant gap for comprehensive analysis
- Cannabis sector showing positive narrative (Motley Fool coverage citing "quietly trouncing the market")
Support/Resistance Levels
| Level | Type | Distance | Significance | |-------|------|----------|--------------| | $10.81 | Support | -3.4% | Lower Bollinger Band; psychological round number | | $10.56 | Support | -5.6% | SMA 50; established intermediate support | | $11.19 | Current | — | Testing resistance at previous support | | $11.81 | Resistance | +5.5% | SMA 20; EMA 12; zone of rejection | | $12.81 | Resistance | +14.4% | Upper Bollinger Band; potential breakout target |
Critical Observation: Current price at midpoint between support and resistance suggests indecision; break of $10.81 would confirm bearish reversal, while move above $11.81 would signal recovery.
Momentum Signals
RSI (14): 46.78 — NEUTRAL
- Reading in optimal neutral zone (30-70), neither overbought nor oversold
- No extremes present; room for price movement in either direction
- Suggests momentum neither exhausted nor accelerating
MACD: BULLISH SIGNAL WITH CAUTION
- MACD line (0.26) trading above signal line (-0.15)
- Positive histogram (0.41) indicates bullish momentum on paper
- Critical caveat: Bullish MACD crossover occurring while price is BELOW moving averages
- This divergence (positive momentum indicator vs negative price action) is a RED FLAG for momentum sustainability
- Suggests momentum may be petering out rather than accelerating
Bollinger Bands: NEUTRAL COMPRESSION
- Width of 16.95% indicates moderate band spacing (not in squeeze)
- Price at $11.19 near middle band ($11.81), in neutral zone
- Not signaling imminent breakout or mean reversion extremes
- Equal distance from upper/lower bands suggests balanced push-pull
Volume-Weighted Momentum Assessment: Despite positive MACD, negative OBV severely undermines bullish conviction. Momentum is present but potentially unreliable.
Volume Analysis
On-Balance Volume: MAJOR RED FLAG
- OBV at -12.8M (negative territory) indicates cumulative selling pressure
- Volume is flowing to sellers despite positive news headlines
- Interpretation: This is institutional or smart money selling into retail optimism
- Negative OBV with positive price action = classic distribution pattern
Volume Rate of Change: +14.74% — ELEVATED
- Volume 14.74% above 20-day SMA (2.73M shares)
- Elevated volume on DOWN days indicates institutional selling conviction
- When volume expands on weakness, it confirms selling pressure
Institutional Activity Signals:
- High call volume (315) vs puts (133) with 0.42 put/call ratio suggests retail bullish enthusiasm
- BUT: Massive open interest in calls (7,210) with only 560 puts suggests call holders (potential sellers from earlier positions)
- Large call OI relative to puts may represent call selling by institutions (taking profits)
Data Quality Assessment: Volume data appears complete and reliable; OBV is particularly valuable here as it contradicts sentiment-driven narratives.
News & Sentiment Analysis
Recent Headlines Summary
Article 1: "Cannabis Stocks That Are Quietly Trouncing the Market in 2026"
- Source: The Motley Fool (2026-09-22) — Recent, timely
- Positive sentiment focused on sector outperformance
- Suggests TRLV or similar names have been market leaders
- Emphasis on "quietly" suggests under-the-radar positioning gaining attention
Article 2: "First U.S. Marijuana Stock Now Trading on NYSE"
- Source: The Motley Fool (2026-06-14) — Historical context (3 months prior to current date)
- Positive sentiment around regulatory/institutional acceptance milestone
- NYSE listing is significant credibility marker for cannabis sector
- Potential catalyst date: June 14, 2026 (suggests institutional access/legitimization)
Sentiment Assessment: POSITIVE (70% Confidence)
- Both headlines are positive without negative counter-narrative
- News focus on sector tailwinds (NYSE accessibility, outperformance) rather than company-specific catalysts
- Critical Gap: No company-specific earnings, product announcements, or operational updates
- Sentiment appears driven by sector momentum rather than TRLV-specific fundamentals
Catalyst Identification
Immediate Catalysts (1-7 days): None identified
- No earnings dates provided
- No regulatory decisions mentioned
- No product launches announced
Near-term (1-4 weeks):
- Potential FDA/regulatory decisions affecting cannabis sector
- Earnings season if applicable (no data provided)
Medium-term (1-3 months):
- Federal cannabis policy developments (ongoing regulatory environment)
- Sector-wide consolidation or partnership opportunities
Data Quality Issue: Earnings information shows "No earnings data available" — significant gap for fundamental analysis in volatile cannabis sector.
Market Narrative Analysis
News vs Technical Signal DIVERGENCE:
| Signal | Status | Implication | |--------|--------|------------| | News Sentiment | POSITIVE | Market optimism present | | Technical Price Action | BEARISH | Price rejecting upside, below MAs | | OBV | NEGATIVE | Smart money selling into enthusiasm | | Options Calls | HIGH VOLUME | Retail/speculation positioning | | IV Premium | ELEVATED (133%) | Options market pricing in outsized moves |
Critical Finding: Positive news narrative is NOT translating to institutional buying (evidenced by negative OBV and falling price). This suggests:
- Market has already priced in the positive
Generated
News
All TRLV news →
Management details Georgia growth and a new federal tax milestone.
Earnings History
1 of 1 under expected move
Avg Expected Move
17.89%
Avg Actual Move
6.03%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2026-11-05 | Pre-Market | 17.89% | 6.03% | 0.34x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
TRLV Options Activity & IV Rank
TRLV IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 117.1%
7-DTE IV: 111.8%
Expected Move: $3.15
7-DTE Move: $1.62
Days to Exp: 39 (2026-12-18)
Options Flow · All expiries
Call Volume: 772
Put Volume: 382
P/C Volume: 0.495
BULLISH
Call OI: 14,196
Put OI: 5,391
P/C OI: 0.38
Total OI: 19,587
ATM Options Pricing
ATM Call: $1.15
ATM Put: $2.00
Call %: 10.6%
Put %: 18.5%
Chain Summary
Chain Volume: 1,154
Chain OI: 19,587
Last Updated: 11/9/2026
Spread Scanner
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Dealer Positioning
LOW γ vs HISTORY
Estimated net dealer gamma is at the 17th percentile of this name's own daily history, near the low end of its range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
17%
vs own history
GEX tilt
+0.33
OI-weighted, today
Vanna tilt
+0.47
δ-sensitivity to IV
Charm tilt
-0.58
δ-decay vs time
Vanna tilt +0.47: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.58: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 10 ATM contracts, 2k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
No data
30 DTE / 10d
—
—
pts
EXTREME
No data
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Loading the implied volatility surface…
Volatility Smile
Loading the implied volatility smile…
IV Rank (7 DTE)22.4LowNov 9
IV Rank (30 DTE)84.2HighNov 9
Straddle Price (30 DTE)$3.15Nov 9
Beta Analysis
Risk Metrics
Beta: 0.7280
Alpha: -1.66%
Correlation: 0.1647
R-Squared: 2.7%
Stock Volatility: 63.4%
Market Volatility: 14.3%
Analysis Details
Benchmark: SPY
Data Points: 105
Period: 252 trading days
Data Points: 105
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own TRLV
1 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Rockefeller Capital Management Family office Rockefeller family | $2K | #4380 of 4729 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
TRLV Institutional Ownership (13F)
Filings for 2026-06-30 · 63 already for 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
2 filers$493.47K notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $267.38K | 54.18% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $226.09K | 45.82% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|
TRLV Insider Trading (Form 4)
Latest: 2026-06-26Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-06-26 | Kim A. Rivers | Chairman and CEO | Sell (S) | −136,811 | $8.76 | -$1.20M | EDGAR |
| 2026-06-25 | Kim A. Rivers | Chairman and CEO | Sell (S) | −1,080,000 | $8.27 | -$8.94M | EDGAR |
| 2026-06-22 | Kim A. Rivers | Chairman and CEO | Sell (S) | −482,196 | $9.39 | -$4.53M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
TRLV Insider Holdings
1 insider · @ $10.83
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Kim A. Rivers | Chairman and CEO | 1,476,913 | $15.99M | -$14.66M | 3 | 2026-06-26 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
TRLV Board & Officers
As of SEC filings through Jun 26, 2026Directors 7
- Kim A. Rivers · since Feb 4, 2021
- Peter Healy · since Feb 4, 2021
- Richard S. May · since Feb 4, 2021
- Susan Thronson · since Feb 4, 2021
- Thomas L Millner · since Feb 4, 2021
- Jane Cecil Morreau · since Jun 10, 2021
- Matthew J. Foulston · since Aug 27, 2025
Officers 9
- Kim A. Rivers · Chairman and CEO · listed since May 2022
- Jan Reese · Chief Financial Officer · since Sep 8, 2025
- Kyle Landrum · Chief Production Officer · since Feb 4, 2021
- Timothy Morey · Chief Sales Officer · since Feb 4, 2021
- Eric Powers · Chief Legal Officer · listed since Jan 2023
- Gina Collins · Chief Marketing Officer · since Jul 17, 2024
- Nilyum Jhala · Chief Technology Officer · since Jul 17, 2024
- Christine Ann Hersey · Chief Corp Affairs & Strategy · since Jan 14, 2026
- Brett R. Walsh · Chief Accounting Officer · since Feb 28, 2026
10% owners 1
- Kim A. Rivers · since Feb 4, 2021
Changes in the last 10 years (46)
| Jun 11, 2026 | The company announced the departure of Jason Pernell as President in an SEC filing |
| Apr 15, 2026 | The company announced the departure of Thad Beshears from the board in an SEC filing |
| Feb 28, 2026 | Brett R. Walsh became Chief Accounting Officer |
| Jan 14, 2026 | Christine Ann Hersey became Chief Corp Affairs & Strategy |
| Sep 8, 2025 | Jan Reese became Chief Financial Officer |
| Aug 27, 2025 | Matthew J. Foulston became a director |
| Mar 11, 2025 | Ryan Blust first listed as Interim CFO in an SEC filing |
| Mar 6, 2025 | The company announced the departure of Wes Getman as Chief Financial Officer in an SEC filing |
| Feb 26, 2025 | Jason Pernell became President |
| Jul 17, 2024 | Nilyum Jhala became Chief Technology Officer |
| Jul 17, 2024 | Gina Collins became Chief Marketing Officer |
| Apr 17, 2024 | The company announced the departure of Giannella Alvarez from the board in an SEC filing |
| Mar 12, 2024 | Thomas L Millner no longer listed as a 10% owner in SEC filings |
| Mar 12, 2024 | Thad Beshears no longer listed as a 10% owner in SEC filings |
| Jan 29, 2024 | Marie Zhang became Chief Operating Officer |
| Jan 16, 2024 | Ryan Blust reported in an SEC filing no longer being Chief Financial Officer |
| Jan 1, 2024 | Wes Getman became Chief Financial Officer |
| Jul 21, 2023 | The company announced the departure of Timothy E Mullany as Chief Financial Officer in an SEC filing |
| Jul 10, 2023 | Timothy E Mullany became Chief Financial Officer |
| Jun 18, 2023 | Ryan Blust became Chief Financial Officer |
| Apr 26, 2023 | Joy Malivuk became Chief Accounting Officer |
| Jan 10, 2023 | The company announced the departure of Rebecca L. Young as Chief Accounting Officer in an SEC filing |
| Jan 3, 2023 | Eric Powers listed as Chief Legal Officer (previously GC and Corporate Secretary) in SEC filings |
| May 25, 2022 | Kim A. Rivers listed as Chairman and CEO (previously President and CEO) in SEC filings |
| Feb 28, 2022 | Thomas L Millner first listed as a 10% owner in an SEC filing |
| Dec 24, 2021 | Steven Matthew White became President |
| Sep 29, 2021 | Rebecca L. Young became Chief Accounting Officer |
| Jun 10, 2021 | Jane Cecil Morreau became a director |
| Jun 10, 2021 | Giannella Alvarez became a director |
| Feb 4, 2021 | Timothy Morey became Chief Sales Officer |
| Feb 4, 2021 | Thomas L Millner became a director |
| Feb 4, 2021 | Thad Beshears became a director |
| Feb 4, 2021 | Thad Beshears became a 10% owner |
| Feb 4, 2021 | Telogia Pharm, LLC became a 10% owner |
| Feb 4, 2021 | Susan Thronson became a director |
| Feb 4, 2021 | Shade Leaf Holding, LLC became a 10% owner |
| Feb 4, 2021 | Richard S. May became a director |
| Feb 4, 2021 | Peter Healy became a director |
| Feb 4, 2021 | Michael Jay ODonnell SR became a director |
| Feb 4, 2021 | Kyle Landrum became Chief Production Officer |
| Feb 4, 2021 | Kim A. Rivers became a director |
| Feb 4, 2021 | Kim A. Rivers became a 10% owner |
| Feb 4, 2021 | Kim A. Rivers became President and CEO |
| Feb 4, 2021 | George Hackney became a director |
| Feb 4, 2021 | Eric Powers became GC and Corporate Secretary |
| Feb 4, 2021 | Alex D'Amico became Chief Financial Officer |
Not reported recently (9)
- Joy Malivuk · Last reported as Chief Accounting Officer in an SEC filing dated Dec 8, 2025
- Ryan Blust · Last reported as Interim CFO in an SEC filing dated Aug 13, 2025
- Marie Zhang · Last reported as Chief Operating Officer in an SEC filing dated Mar 28, 2025
- Alex D'Amico · Last reported as Chief Financial Officer in an SEC filing dated Jan 3, 2023
- Steven Matthew White · Last reported as President in an SEC filing dated May 25, 2022
- Telogia Pharm, LLC · Last reported as a 10% owner in an SEC filing dated Feb 14, 2022
- Shade Leaf Holding, LLC · Last reported as a 10% owner in an SEC filing dated Feb 14, 2022
- George Hackney · Last reported as a director in an SEC filing dated Apr 13, 2021
- Michael Jay ODonnell SR · Last reported as a director in an SEC filing dated Feb 4, 2021
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
TRLV Proposed Insider Sales (Form 144)
Latest: 2026-06-17
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
0 filings
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-06-17 | Rivers Kim A. | Officer, 10% Stockholder | 1,699,007 | $17.84M | 2026-06-17 | WILSON DAVIS | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-11-05
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
| Filing Date | Event | Link |
|---|---|---|
| 2026-11-05 | Earnings results · Regulation FD disclosure | EDGAR |
| 2026-08-11 | Material agreement · Unregistered share sale · Shareholder rights change · Bylaws or fiscal year change | EDGAR |
| 2026-08-07 | Acquisition or sale completed · Regulation FD disclosure | EDGAR |
| 2026-08-05 | Shareholder vote results | EDGAR |
| 2026-07-02 | Director or officer change | EDGAR |
| 2026-06-12 | Director or officer change | EDGAR |
| 2026-06-11 | Shareholder vote results | EDGAR |
| 2026-06-09 | Other events | EDGAR |
| 2026-06-04 | Material agreement · Acquisition or sale completed | EDGAR |
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
| Filing Date | Accession | Link |
|---|
ETF Holders
14 ETFs hold TRLV
14 shown · $166.13M total exposure · 0.02% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | MSOS AdvisorShares Pure US Cannabis ETF | Nport | 9.56% | $100.1M | — | 2026-06-30 |
| 2 | VXF Vanguard Extended Market ETF | Vanguard | 0.02% | $20.9M | — | 2026-09-30 |
| 3 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $15.2M | — | 2026-09-30 |
| 4 | CNBS Amplify Seymour Cannabis ETF | Amplify | 16.42% | $11.0M | $67.1M | 2026-11-06 |
| 5 | FYC First Trust Small Cap Growth AlphaDEX® Fund | First Trust | 0.56% | $7.3M | $1.3B | 2026-11-06 |
| 6 | YOLO AdvisorShares Pure Cannabis ETF | Nport | 13.09% | $4.5M | — | 2026-06-30 |
| 7 | FYX First Trust Small Cap Core AlphaDEX® Fund | First Trust | 0.26% | $3.6M | $1.4B | 2026-11-06 |
| 8 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.00% | $2.6M | $93.2B | 2026-11-06 |
| 9 | FAD First Trust Multi Cap Growth AlphaDEX® Fund | First Trust | 0.12% | $659,163 | $570.9M | 2026-11-06 |
| 10 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.00% | $69,596 | — | 2026-11-05 |
| 11 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.00% | $36,078 | — | 2026-11-05 |
| 12 | DFAT Dimensional US Targeted Value ETF | Dimensional | 0.00% | $36,056 | — | 2026-11-05 |
| 13 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.00% | $30,629 | — | 2026-11-05 |
| 14 | DFUS Dimensional US Equity Market ETF | Dimensional | 0.00% | $15,325 | $20.9B | 2026-11-05 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
—
TTM Diluted EPS
—
TTM Revenue
—
TTM Net Income
—
TTM Op. Cash Flow
—
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
2.73
P/S
1.84
EV/EBITDA
7.49
EV/Sales
1.98
ROE
-61.7%
ROA
-22.8%
Div Yield
0.69%
FCF Yield
8.89%
Debt/Equity
0.63
Current Ratio
5.94
Market Cap
$2.10B
as of 2026-11-05
TRLV vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings, Inc. Common St | $2.8B | — | +38.4% | +113.1% | 15 |
| TRLV Trulieve Cannabis Corp. | $2.0B | — | — | −5.8% | 84 |
| CRON Cronos Group Inc. Common Share | $1.3B | 18.0 | +32.0% | +33.5% | 83 |
| TLRY Tilray Brands, Inc. Common Stock | $432M | — | +15.9% | −70.5% | 72 |
| SNDL Sundial Growers Inc. Common Shares | $346M | — | — | −19.3% | 12 |
| ACB Aurora Cannabis Inc. Common Shares | $345M | — | — | +19.5% | 8 |
| CGC Canopy Growth Corporation Common Shares | $276M | — | +11.3% | −47.2% | 62 |
| GLAS Glass House Brands Inc. | $196M | — | — | −85.0% | 100 |
| OGI Organigram Global Inc. Common Shares | $124M | — | — | −49.2% | 26 |
| Peer median | $345M | 18.0 | +23.9% | −33.2% | 44 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
7.26M
SI % of Float
4.43%
Days to Cover
4.53
Short Vol Ratio
54.9%
Free Float
163.90M
Float %
96.3%
Short interest 2026-10-15 • Short volume 2026-11-06 • Float 2026-08-17